Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $23.4900 (-0.09%) ($23.4100 - $24.0000) on Wed. Jun. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.41% (three month average) | RSI | 51 | Latest Price | $23.4900(-0.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.2% a day on average for past five trading days. | Weekly Trend | HALO declines -1.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(51%) IBB(50%) IWM(47%) IWC(45%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -1.705% in a week (0% probabilities). VIXM(-31%) UUP(-16%) VXX(-14%) TLT(-3%) IYT(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.705% (StdDev 3.41%) | Hourly BBV | 0 () | Intraday Trend | -1% | | | |
|
1 - 5 Day Possible Target | $19.39(-17.45%) | Resistance Level | $23.73 | 5 Day Moving Average | $23.2(1.25%) | 10 Day Moving Average | $23.39(0.43%) | 20 Day Moving Average | $23.73(-1.01%) | To recent high | -5.4% | To recent low | 69% | Market Cap | $3.21b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |